PRESS RELEASE published on 08/24/2026 at 08:05, 2 months 21 days ago TME Pharma provides update on its activities TME Pharma provides update on its activities including final evaluation phase with potential partners for NOX-A12, with estimated peak sales potential of $1 billion, strategic decision framework, and scientific validation Clinical-stage Biotechnology License Agreement TME Pharma NOX-A12 Brain Cancer
PRESS RELEASE published on 08/24/2026 at 08:05, 2 months 21 days ago TME Pharma fait le point sur ses activités TME Pharma fait le point sur ses activités et les négociations pour un accord de licence pour NOX-A12, médicament phare pour le cancer du cerveau. Analyse stratégique en cours Biotechnologie Accord De Licence TME Pharma NOX-A12 Cancer Du Cerveau
BRIEF published on 10/30/2025 at 21:05, 1 year ago TME Pharma's Semi-Annual Report and Financial Restructuring Financial Results Biotechnology CEO Appointment Bond Issuance TME Pharma
BRIEF published on 10/30/2025 at 21:05, 1 year ago Rapport semestriel et restructuration financière de TME Pharma Résultats Financiers Biotechnologie Emission D'obligations Nomination Du PDG TME Pharma
PRESS RELEASE published on 10/30/2025 at 21:00, 1 year ago TME Pharma publishes its semi annual results and half-year report TME Pharma publishes semi annual results and half-year report showing cost reductions, new CEO, and fundraising activities. Focus on NOX-A12 and NOX-E36 assets Fundraising Cost Reductions TME Pharma NOX-A12 Semi Annual Results
PRESS RELEASE published on 09/01/2025 at 08:45, 1 year 2 months ago Inside Information: Other news releases TME Pharma completes August financing, with €500k cash received on August 28th, bringing cash position to €2.35M. Organization aims to attract financing for cancer and eye therapies Cash Position TME Pharma August Financing Cost-efficient Organization Novel Therapies
BRIEF published on 09/01/2025 at 08:45, 1 year 2 months ago TME Pharma conclut avec succès sa levée de fonds d'août Biotechnologie Trésorerie Levée De Fonds Cryptomonnaies Cancer
BRIEF published on 09/01/2025 at 08:45, 1 year 2 months ago TME Pharma successfully completes its August fundraising round Biotechnology Fundraising Treasury Cryptocurrencies Cancer
PRESS RELEASE published on 09/01/2025 at 08:40, 1 year 2 months ago Informations privilégiées:Autres communiqués TME Pharma finalise une levée de fonds de 500 k € en espèces en août, atteignant une trésorerie de 2,35 M € pour développer de nouvelles thérapies contre le cancer et les maladies oculaires Trésorerie Levée De Fonds Cancer TME Pharma Thérapies
BRIEF published on 08/25/2025 at 08:05, 1 year 2 months ago TME Pharma Secures €500,000 through New Bond Issue Investment Strategy Cost Reduction Bond Issuance Financial Strategy Shareholder Commitments
Published on 11/14/2026 at 12:56, 11 hours 26 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 22 hours 52 minutes ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 23 hours 42 minutes ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 23 hours 47 minutes ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 2 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 5 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 5 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 12 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 12 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 16 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 1 hour ago Belgrano continues the implementation of its public share buyback offer (OPRA)
